Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Fagerberg & Dellby
Mandate

Vinge advises Fagerberg & Dellby

June 02, 2010

Vinge is advising Fagerberg & Dellby in connection with its acquisition of a majority stake in YrkesAkademin. YrkesAkademin, with sales of approximately SEK 400 million and roughly 350 employees, is one of Sweden’s leading private vocational education companies for adults and sixth form students. The company’s registered office is situated in Falun and it provides educational courses in fourty locations in Sweden. Fagerberg & Dellby invests in Swedish family businesses and is owned by its founders, Christina Fagelberg and Ulrika Dellby, together with several other family business owners and pension funds.

Vinge’s team advising Fagerberg & Dellby consists of partners Fabian Ekebald and Malin Leffler together with, among others, associates Jonas Johansson and Sofia Berg.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026